Intrinsiqq
Alector Inc. logo

Alector Inc. Financials

ALEC

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 10 available years
Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$14$21$101$97$134$207
General & Administrative$41$54$60$57$61$55
Research & Development$99$123$186$192$210$189
Total Operating Expenses$140$177$246$249$271$244
Operating Income-$126-$156-$145-$152-$138-$37
Other Non-Operating Income (Expense)$9$13$26$27$8$1
EBT (Earnings Before Tax)-$118-$143-$119-$125-$130–
Income Tax Expense$0$0$0$5$3$0
Net Income
Net Income-$118-$143-$119-$130-$133-$36
Per Share Data
Revenue Per Share$0.12$0.20$1.04$1.16$1.62$2.58
EPS (Basic)-$1.10-$1.39-$1.23-$1.56-$1.62-$0.45
EPS (Diluted)-$1.10-$1.39-$1.23-$1.56-$1.62-$0.45
Weighted Avg Shares (Basic)111.2M103.0M96.6M83.7M82.5M80.4M
Weighted Avg Shares (Diluted)111.2M103.0M96.6M83.7M82.5M80.4M
Shares Outstanding111.2M103.0M96.6M83.7M82.5M80.4M

Alector (ALEC) financials: revenue, profit and margins

Alector (ALEC) generated about $14 million in revenue and -$118 million in net income (a -851.7% net margin) over the trailing twelve months, growing at roughly -0.1% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Alector's (ALEC) revenue?+

Alector generated about $14 million in revenue over the trailing twelve months. Revenue has grown at roughly -0.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Alector profitable?+

Alector reported about -$118 million in net loss over the trailing twelve months, a net margin of roughly -851.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Alector's profit margins?+

Alector runs an operating margin of about -914.1%, a net margin of about -851.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Alector growing?+

Alector's revenue has compounded at roughly -0.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ALEC's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 7 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ALEC

CompareIntrinsic value
CRSPCrispr Therapeutics AG
$51.78+3.57%40
LCTXLineage Cell Therapeutics Inc.
$1.03+1.98%10
ELUTElutia Inc.
$0.76-6.52%20
CRBUCaribou Biosciences, Inc.
$0.44-3.27%10
PTHSPelthos Therapeutics Inc.
$10.15-5.84%0
ACOGAlpha Cognition Inc.
$8.49+3.48%10
RLAYRelay Therapeutics Inc.
$18.03+3.38%40
TCRXTScan Therapeutics Inc.
$0.21+11.11%10

Held by ETFs

ALEC is in 8 US ETFs. The largest of them, with ALEC's weight in each:

Spot a number that looks wrong? Check it in ALEC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALEC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.